- Home
- ARWR vs PDO Comparison
ARWR vs PDO Comparison
Compare ARWR & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- PDO
- Stock Information
- Founded
- ARWR 2003
- PDO 2020
- Country
- ARWR United States
- PDO United States
- Employees
- ARWR N/A
- PDO N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- PDO Trusts Except Educational Religious and Charitable
- Sector
- ARWR Health Care
- PDO Finance
- Exchange
- ARWR Nasdaq
- PDO Nasdaq
- Market Cap
- ARWR 1.8B
- PDO 1.7B
- IPO Year
- ARWR 1993
- PDO N/A
- Fundamental
- Price
- ARWR $18.31
- PDO $13.40
- Analyst Decision
- ARWR Buy
- PDO
- Analyst Count
- ARWR 8
- PDO 0
- Target Price
- ARWR $43.71
- PDO N/A
- AVG Volume (30 Days)
- ARWR 1.6M
- PDO 520.0K
- Earning Date
- ARWR 08-07-2025
- PDO 01-01-0001
- Dividend Yield
- ARWR N/A
- PDO 11.80%
- EPS Growth
- ARWR N/A
- PDO N/A
- EPS
- ARWR N/A
- PDO N/A
- Revenue
- ARWR $545,209,000.00
- PDO N/A
- Revenue This Year
- ARWR $21,924.50
- PDO N/A
- Revenue Next Year
- ARWR N/A
- PDO N/A
- P/E Ratio
- ARWR N/A
- PDO N/A
- Revenue Growth
- ARWR 1436.97
- PDO N/A
- 52 Week Low
- ARWR $9.57
- PDO $10.65
- 52 Week High
- ARWR $30.41
- PDO $13.31
- Technical
- Relative Strength Index (RSI)
- ARWR 66.51
- PDO 47.13
- Support Level
- ARWR $16.45
- PDO $13.41
- Resistance Level
- ARWR $19.24
- PDO $13.55
- Average True Range (ATR)
- ARWR 0.79
- PDO 0.07
- MACD
- ARWR 0.25
- PDO 0.01
- Stochastic Oscillator
- ARWR 77.43
- PDO 48.31
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.